Dr. Wendy Harpham is a doctor of internal medicine, cancer survivor, and award-winning and best-selling author of books about cancer: Healthy Survivorship, recovery and late effects, and raising children when a parent has cancer. She is also a public speaker, patient advocate, and mother of three.
Dr. Youn asks, "Would it have been preferable for Jerry’s wife to see him sedated, peaceful and for her to cling to the slight hope that he might survive? Or would it have eased her loss to have had the opportunity to say goodbye, even if it meant seeing him in grave pain?"
In my last post, Hope or Letting Go, I shared the story of a physician, Dr. Youn, still troubled by an incident that happened ten years ago. Since reading it, I've been bothered by some of the questions he posed.
For example, Dr. Youn asked if concern for the needs of the patient's loved ones ever take precedence over the patients' needs?
Should doctors give patients' loved ones hope no matter the situation? Or should they allow loved ones to say goodbye when a situation seems hopeless? In Hope or Letting Go: The Final Good-bye.Dr. Anthony Youn describes why these questions have been haunting him for years.
Wow, it's been a long time since our last microvacation.* The 2 3/4-minute video of a young girl playing piano despite missing fingers on her right hand illustrates an important idea about limits and Healthy Survivorship.
In recent posts, I discussed a NYTimes article about research techniques used and marketed before prime time. If patients can receive treatment from of team of professionals at a major university in a clinical trial that turns out to be based on wrong information, what's a survivor to do?
This post has time-sensitive information, so bear with me for one more interruption before I go back to the mini-series on news of promising research on tumor-gene analysis that led to premature use and marketing of the technique.
Beauty is only skin deep, while cancer is life or death. Still, when going through cancer treatment, attention to appearance can make a huge difference in how a patient feels about him- or herself. It can boost confidence during trying times.
The current mini-series of posts on this blog reflects my response to a news story of promising research on tumor-gene analysis that led to premature use and marketing of the technique. Let me stop for a post to clarify an important point about molecular testing.
My last post briefly summarized the full story of promising research on tumor-gene analysis that led to premature use and marketing of the technique. How could this happen at well-respected research institutions?
Patients are not Healthy Survivors if they believe the promises of charlatans. What about patients who receive treatment from of team of professionals at a major university in a clinical trial that turns out to be based on wrong information?